[Research advances on inhibitor of apoptosis, survivin]

Jing Yang1, Feng-Xuan Liu, Xiao-Chu Yan

  • 1Pathology Institute, Southwest Hospital, The Third Military Medical University, Chongqing, 400038, PR China. yangjing16@yahoo.com

Insights

Survivin, a key inhibitor of apoptosis, regulates cell division and promotes cancer growth. Targeting survivin shows promise for cancer treatment by inducing cell death and enhancing therapy effectiveness.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Biology

Background:

  • Survivin is a novel inhibitor of apoptosis.
  • Survivin expression is linked to cell cycle regulation, specifically the G(2)/M phase.
  • Increased survivin expression correlates with poor prognosis in human cancers.

Purpose of the Study:

  • To investigate the role of survivin in cancer.
  • To explore survivin as a potential therapeutic target for cancer treatment.

Main Methods:

  • Studied survivin's association with mitotic spindle microtubules.
  • Investigated survivin's inhibition of caspase-3 and caspase-7 activity.
  • Utilized survivin-targeting antisense nucleotides and survivin mutants in vitro and in vivo.

Main Results:

  • Survivin expression is inversely correlated with apoptosis and positively correlated with proliferation and angiogenesis during tumorigenesis.
  • Survivin up-regulation predicts short survival and poor prognosis.
  • Targeting survivin induced apoptosis, reduced tumor growth, and sensitized cancer cells to chemotherapy and irradiation.

Conclusions:

  • Survivin plays a critical role in cancer development and progression.
  • Survivin represents a potential novel target for cancer diagnosis and therapy.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...